RESEARCH & DEVELOPMENT
A Leap Forward in Oncology
Programs in development
CellmAbs has been developing several therapeutic modalities targeting cancer-specific glycans using a unique mAb development platform.
We develop innovative solutions to provide the most effective treatments to patients, and we are partnering with biotech/pharma companies and international clinical institutes.
Last updated: May, 2022